Table 7.
Association between BMI and Cancer Clincopathological Features of Breast Cancer
| Obesity | Over weight | Normal | P-value | |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||
| Subtype | ||||
| ER+/PR+/HER2− (n=76) | 47 (61.8) | 18 (23.7) | 11 (14.5) | 0.876 |
| ER+/PR+/HER2+ (n=18) | 13 (72.2) | 4 (22.2) | 1 (5.6) | |
| ER−/PR−/HER2+ (n=30) | 17 (56.7) | 9 (30.0) | 4 (13.3) | |
| ER−/PR−/HER2− (n=61) | 36 (59.0) | 18 (29.5) | 7 (11.5) | |
| ER/PR status | ||||
| ER/PR positive (n=116) | 73 (62.9) | 29 (25.0) | 14 (12.1) | 0.595 |
| ER/PR negative (n=92) | 53 (57.6) | 28 (30.4) | 11 (12.0) | |
| HER2 status | ||||
| HER2 negative (n=137) | 83 (60.6) | 36 (26.3) | 18 (13.1) | 0.696 |
| HER2 positive (n=48) | 30 (62.5) | 13 (27.1) | 5 (10.4) | |
| Tumor size | ||||
| T0/Tis/T1 (n=51) | 30 (23.4) | 15 (25.9) | 6 (25.0) | 0.538 |
| T2 (n=95) | 58 (45.3) | 24 (41.4) | 13 (54.2) | |
| T3/T4 (n=64) | 40 (31.3) | 19 (32.8) | 5 (20.8) | |
| Lymph node | ||||
| Negative (n=81) | 50 (40.3) | 26 (44.8) | 5 (21.7) | 0.292 |
| Positive (n=124) | 74 (59.7) | 32 (55.2) | 18 (78.3) | |
| Stage | ||||
| 0–II (n=143) | 81 (62.8) | 43 (72.9) | 19 (79.2) | 0.062 |
| III–IV (n=69) | 48 (37.2) | 16 (27.1) | 5 (20.8) |